ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Market Movers(Regular)

View all
NasdaqNYSEAMEXOTCTSXEuronextLSE

NASDAQ Market Status

Advancing
2,308(57.82%)
Declining
1,662(41.63%)
Unchanged
22(0.55%)
  • % Gainers
  • % Losers
  • Most Active
TickerNamePriceChangeChange %Volume
AVTX LogoAVTXAvalo Therapeutics Inc23.1718.42387.79%23,050,466
XLO LogoXLOXilio Therapeutics Inc1.4240.785122.85%29,658,993
NXL LogoNXLNexalin Technologies Inc1.650.87111.54%6,854,154
BDRX LogoBDRXBiodexa Pharmaceuticals PLC1.5260.66777.65%84,026,749
CERO LogoCEROCERo Therapeutics Holdings Inc2.831.2073.62%19,064,564
KYCH LogoKYCHKeyarch Acquisition Corporation11.504.4964.16%168,952
MESO LogoMESOMesoblast Limited4.991.5042.98%12,531,026
PIK LogoPIKKidpik Corporation4.401.1334.56%9,140,451
NTRB LogoNTRBNutriband Inc5.441.3934.32%463,393
OTLK LogoOTLKOutlook Therapeutics Inc12.423.0532.55%1,330,674
IMNN LogoIMNNImunon Inc1.80980.409829.27%1,152,892
BOLD LogoBOLDBoundless Bio Inc14.79-45.18-75.34%557,096
PMEC LogoPMECPrimech Holdings Ltd1.40-2.48-63.92%6,713,539
GMDA LogoGMDAGamida Cell Ltd0.0357-0.0235-39.70%76,901,187
NBSTW LogoNBSTWNewbury Street Acquisition Corporation0.042279-0.02622-38.28%1,750
TNXP LogoTNXPTonix Pharmaceuticals Holding Corporation0.2198-0.1071-32.76%16,714,969
NDRA LogoNDRAENDRA Life Sciences Inc0.5897-0.2306-28.11%698,658
KOD LogoKODKodiak Sciences Inc5.413-2.04-27.34%2,085,639
DTST LogoDTSTData Storage Corporation5.70-1.94-25.39%701,771
UGRO LogoUGROUrban Gro Inc1.3701-0.4449-24.51%483,546
AWIN LogoAWINAERWINS Technologies Inc0.0578-0.0166-22.31%2,260,200
AKBA LogoAKBAAkebia Therapeutics Inc1.795-0.445-19.87%54,234,121
NKLA LogoNKLANikola Corporation1.030.120913.30%140,040,177
BDRX LogoBDRXBiodexa Pharmaceuticals PLC1.5260.66777.65%84,026,749
GMDA LogoGMDAGamida Cell Ltd0.0357-0.0235-39.70%76,901,187
MARA LogoMARAMarathon Digital Holdings Inc22.980.914.12%71,725,921
AKAN LogoAKANAkanda Corporation0.148-0.0169-10.25%68,330,142
CISS LogoCISSC3is Inc0.0362-0.002-5.24%58,189,356
TSLA LogoTSLATesla Inc176.77-3.06-1.70%57,539,298
AKBA LogoAKBAAkebia Therapeutics Inc1.795-0.445-19.87%54,234,121
SQQQ LogoSQQQProShares UltraPro Short QQQ10.46470.06470.62%52,899,457
AMD LogoAMDAdvanced Micro Devices Inc180.641.050.58%44,430,905
TLRY LogoTLRYTilray Brands Inc2.445-0.035-1.41%43,245,558
TradesView all

Big Movers

11:00
Business Wire

Gilead Sciences, Inc. (Nasdaq: GILD) and Xilio Therapeutics, Inc. (Nasdaq: XLO) today announced an exclusive license agreement to develop and commercialize Xilio’s Phase 1 tumor-activated IL-12 program, XTX301.

12:30
PR Newswire (US)

SINGAPORE, March 28, 2024 /PRNewswire/ -- Primech Holdings Limited (Nasdaq: PMEC) ("Primech" or the "Company"), an established technology-driven facilities services provider in the public and private sectors operating mainly in Singapore, provides a financial and corporate update coincident with the filing of the Company's financial results for the six months ended September 30, 2023. These financial results are for periods prior to the Company's initial public offering ("IPO") in October of 2023.

12:02
Business Wire

Kidpik Corp. (NASDAQ: PIK) ("kidpik” or the "Company"), an online clothing subscription-based e-commerce company, today announced that the Company received written notification from the Listing Qualification Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that is has regained full compliance with the Minimum Bid Price Requirement.

10:30
PR Newswire (US)

Three clinical programs present diversified opportunities in and outside the existing anti-VEGF market and are being progressed toward Phase 3 value inflection points  New Phase 3 GLOW2 study of tarcocimab in diabetic retinopathy actively recruiting  Phase 1b study of KSI-101 planned for 2Q2024 with the goal of initiating dual pivotal studies in 2024  New Phase 3 DAYBREAK study in wet AMD to include KSI-501 and tarcocimab investigational groups versus aflibercept targeted to start recruitment mid-2024 following completion of FDA discussions  Investor day to be scheduled after on-going regulatory interactions completedPALO ALTO, Calif., March 28, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and ...

Ticker Buzz Cloud
What is the Buzz Cloud?
  • The Buzz Cloud keeps track of how often tickers are mentioned to indicate the "level of buzz".
  • The larger the text, the more often the ticker is mentioned by the community.
  • You can use this page to spot trading opportunities based on the increase or decrease in the level of buzz.

Unlock more advanced trading tools

Join ADVFN today

Top Cryptocurrencies

View All Cryptos
Crypto Market Status
Advancing
9016(34%)
Declining
2864(10%)
Unchanged
14468(56%)
Ticker Name Price Change Change % Market Cap Volume
BTCBitcoin70,693.611,229.041.77%1.39T5,924,400,454
ETHEthereum3,562.3762.311.78%428.44B3,011,796,586
USDTTether USD0.999920.000480.05%97.83B778,178,608
BNBBinance Coin582.248.121.41%92.11B420,462,148
SOLSolana185.95-0.190-0.10%82.28B1,299,865,812
STETHstETH3,552.3087.872.54%34.86B5,686,979
XRPRipple0.62930.01782.91%34.39B470,233,109
DOGEDogecoin0.220020.0299815.78%31.77B2,737,450,589
USDCUSD Coin0.99997-0.000030.00%28.07B1,323,830,752
ADACardano0.65060.00280.43%22.91B153,952,924

Economic Calendar

This week's major US economic reports, Fed Speakers, indicators and market-moving events.
View full calendar